Related Experiment Video
Updated: Apr 18, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
[Clinical features of peripheral neuropathy in paraproteinemic hemoblastosis]
Objective:
Peripheral neuropathy often occurs as a side effect of medication or as a manifestation of system disease. The purpose of this study was to evaluate the features of polyneuropathy with verified paraproteinemic hemoblastosis.
Material And Methods:
We studied 104 patients, 72 women 32 men, aged 24-79 years. Along with neurological examination, authors studied vibration sensitivity and used electromyography and several scales for assessment of pain syndrome and other clinical presentations. RESULTS AND СONCLUSION: Clinical variants of peripheral neuropathy - neuropathy associated with paraproteinemia and neuropathy during treatment of advanced multiple myeloma with bortezomib (bortezomib-induced neuropathy), were singled out. An algorithm for the examination and treatment of patients with peripheral neuropathy was proposed.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Neuropathy
Chronic Kidney Disease II: Clinical Manifestations
Type I Diabetes III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Peripheral Artery Disease IV: Nursing Management